NCT00000401View on ClinicalTrials.gov

Oral Collagen for Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

July 31, 1999

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Oral bovine type II collagen

Drug can be interrupted or stopped for suspected adverse events.

Trial Locations (2)

38163

University of Tennessee, Memphis, Memphis

38301

The Arthritis Clinic of Jackson, PLLC, Jackson

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

University of Tennessee

OTHER

NCT00000401 - Oral Collagen for Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter